Risk factors for venous thromboses in patients with rheumatoid arthritis
Сатyбалдьева М. А., Решетняк Т. М., Середавкина Н. В., Глухова С. И., Насонов Е. Л.
Научно-практическая ревматология
Т. 56, Вып. 6, С. 692-696
Опубликовано: 2018
Тип ресурса: Статья
DOI:10.14412/1995-4484-2018-692-696
Аннотация:
Objective: to determine risk factors (RFs) for venous thromboembolic events (VTE) in patients with rheumatoid arthritis (RA). Subjects and methods: The investigation enrolled 374 patients (311 women and 63 men) with a reliable diagnosis of RA who met the 2010 ACR/EULAR classification criteria. The patients' mean age was 53.7±13.6 years; the disease duration was 12.1±10.7 years. All the patients were treated at the V.A. Nasonova Research Institute of Rheumatology Clinic during the period from 2014 to 2017. A standard clinical examination of the peripheral joints was performed. RA activity was measured using DAS28. A survey was made using a questionnaire including questions on traditional RFs for VTE and RFs that might be caused by RA and its therapy. Results and discussion. VTE were recorded in 45 (12[%]) out of the 374 patients. Group 1 included 45 patients with VTE; Group 2 consisted of 329 patients without VTE. Multidimensional analysis showed an increased risk of developing VTE in RA
Ключевые слова:
Rheumatoid arthritis; Risk factors; Venous thromboembolic events; Venous thrombosis
Язык текста: Русский
ISSN: 1995-4492
Сатyбалдьева М. А.
Решетняк Т. М.
Середавкина Н. В.
Глухова С. И.
Насонов Е. Л. Евгений Львович 1948-
Satybaldyeva M. A.
Reshetnyak T. M.
Seredavkina N. V.
Glukhova S. I.
Nasonov E. L. Evgenij L`vovich 1948-
Risk factors for venous thromboses in patients with rheumatoid arthritis
Текст визуальный непосредственный
Научно-практическая ревматология
ИМА-Пресс
Т. 56, Вып. 6 С. 692-696
2018
Статья
Rheumatoid arthritis Risk factors Venous thromboembolic events Venous thrombosis
Objective: to determine risk factors (RFs) for venous thromboembolic events (VTE) in patients with rheumatoid arthritis (RA). Subjects and methods: The investigation enrolled 374 patients (311 women and 63 men) with a reliable diagnosis of RA who met the 2010 ACR/EULAR classification criteria. The patients' mean age was 53.7±13.6 years; the disease duration was 12.1±10.7 years. All the patients were treated at the V.A. Nasonova Research Institute of Rheumatology Clinic during the period from 2014 to 2017. A standard clinical examination of the peripheral joints was performed. RA activity was measured using DAS28. A survey was made using a questionnaire including questions on traditional RFs for VTE and RFs that might be caused by RA and its therapy. Results and discussion. VTE were recorded in 45 (12[%]) out of the 374 patients. Group 1 included 45 patients with VTE; Group 2 consisted of 329 patients without VTE. Multidimensional analysis showed an increased risk of developing VTE in RA